Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
67.42
-0.54 (-0.79%)
At close: Apr 18, 2024, 4:00 PM
67.95
+0.53 (0.79%)
After-hours: Apr 18, 2024, 7:28 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
The 23 analysts with 12-month price forecasts for Boston Scientific stock have an average target of 68.04, with a low estimate of 55 and a high estimate of 80. The average target predicts an increase of 0.92% from the current stock price of 67.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BSX stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 10 | 10 | 11 |
Buy | 8 | 10 | 10 | 10 | 10 | 10 |
Hold | 3 | 3 | 3 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 22 | 22 | 22 | 22 | 23 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $70 → $78 | Buy | Maintains | $70 → $78 | +15.69% | Apr 15, 2024 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $68 → $72 | Buy | Maintains | $68 → $72 | +6.79% | Apr 4, 2024 |
Argus Research | Argus Research | Strong Buy Maintains $69 → $80 | Strong Buy | Maintains | $69 → $80 | +18.66% | Apr 3, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $71 → $79 | Strong Buy | Maintains | $71 → $79 | +17.18% | Apr 3, 2024 |
TD Cowen | TD Cowen | Buy Maintains $65 → $77 | Buy | Maintains | $65 → $77 | +14.21% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
15.73B
from 14.24B
Increased by 10.48%
Revenue Next Year
17.20B
from 15.73B
Increased by 9.33%
EPS This Year
2.28
from 1.07
Increased by 112.64%
EPS Next Year
2.58
from 2.28
Increased by 13.36%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 16.7B | 18.5B | 20.2B | 21.5B | 22.8B |
Avg | 15.7B | 17.2B | 18.8B | 19.6B | 21.7B |
Low | 15.1B | 16.3B | 17.6B | 16.7B | 20.9B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 17.1% | 17.8% | 17.7% | 14.7% | 16.4% |
Avg | 10.5% | 9.3% | 9.1% | 4.2% | 10.9% |
Low | 6.0% | 3.6% | 2.1% | -10.8% | 6.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.43 | 2.75 | 3.14 | 3.35 | 3.74 |
Avg | 2.28 | 2.58 | 2.90 | 3.15 | 3.54 |
Low | 2.12 | 2.45 | 2.71 | 2.84 | 3.37 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 126.7% | 20.9% | 21.7% | 15.5% | 18.7% |
Avg | 112.6% | 13.4% | 12.5% | 8.6% | 12.2% |
Low | 97.8% | 7.7% | 5.2% | -2.0% | 7.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.